- Abstract viewed - 2332 times
- PDF downloaded - 691 times
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Affiliations
Gábor Lakatos
Dept. Oncology, St. Istvan and St. Laszlo Hospital and Out- Patient Department, Budapest, Hungary
Anita Balázs
1st Dept. Medicine, University of Szeged, Hungary
Balázs Kui
1st Dept. Medicine, University of Szeged, Hungary
Szilárd Gódi
1st Dept. Medicine, University of Pécs, Hungary
Ákos Szücs
1st Dept. Surgery, Semmelweis University, Budapest, Hungary
Andrea Szentesi
1st Dept. Medicine, University of Szeged, Hungary
Zsolt Szentkereszty
Institute of Surgery, Clinical Center, University of Debrecen, Hungary
Richárd Szmola
Dept. Interventional Gastroenterology, National Institute of Oncology, Budapest, Hungary
Dezső Kelemen
Dept. Surgery, University of Pécs, Hungary
Róbert Papp
Dept. Surgery, University of Pécs, Hungary
Áron Vincze
1st Dept. Medicine, University of Pécs, Hungary
József Czimmer
1st Dept. Medicine, University of Pécs, Hungary
Gabriella Pár
1st Dept. Medicine, University of Pécs, Hungary
Judit Bajor
1st Dept. Medicine, University of Pécs, Hungary
Imre Szabó
1st Dept. Medicine, University of Pécs, Hungary
Ferenc Izbéki
1st Dept. Medicine, Szent György University Teaching Hospital of County Fejér, Székesfehérvár, Hungary
Adrienn Halász
1st Dept. Medicine, Szent György University Teaching Hospital of County Fejér, Székesfehérvár, Hungary
László Leindler
Dept. Surgery, University of Szeged, Hungary
Gyula Farkas Jr.
Dept. Surgery, University of Szeged, Hungary
Tamás Takács
1st Dept. Medicine, University of Szeged, Hungary
László Czakó
1st Dept. Medicine, University of Szeged, Hungary
Zoltán Szepes
1st Dept. Medicine, University of Szeged, Hungary
Péter Hegyi
1st Dept. Medicine, University of Szeged ; Hungarian Academy of Sciences, University of Szeged, Momentum Gastroenterology Multidisciplinary Research Group ; Institute for Translational Medicine & 1st Department of Medicine, University of Pécs; 12) Dept. Oncotherapy, University of Szeged, Hungary
Zsuzsanna Kahán
Dept. Oncotherapy, University of Szeged, Hungary
How to Cite
Pancreatic Cancer: Multicenter Prospective Data Collection and Analysis by the Hungarian Pancreatic Study Group
- Gábor Lakatos ,
- Anita Balázs ,
- Balázs Kui ,
- Szilárd Gódi ,
- Ákos Szücs ,
- Andrea Szentesi ,
- Zsolt Szentkereszty ,
- Richárd Szmola ,
- Dezső Kelemen ,
- Róbert Papp ,
- Áron Vincze ,
- József Czimmer ,
- Gabriella Pár ,
- Judit Bajor ,
- Imre Szabó ,
- Ferenc Izbéki ,
- Adrienn Halász ,
- László Leindler ,
- Gyula Farkas Jr. ,
- Tamás Takács ,
- László Czakó ,
- Zoltán Szepes ,
- Péter Hegyi ,
- Zsuzsanna Kahán
Abstract
Background & Aims: Pancreatic cancer is a devastating disease with poor prognosis. There is very limited information available regarding the epidemiology and treatment strategies of pancreatic cancer in Central Europe. The purpose of the study was to prospectively collect and analyze data of pancreatic cancer in the Hungarian population.
Methods: The Hungarian Pancreatic Study Group (HPSG) organized prospective, uniform data collection. Altogether 354 patients were enrolled from 14 Hungarian centers.
Results: Chronic pancreatitis was present in 3.7% of the cases, while 33.7% of the patients had diabetes. Family history for pancreatic cancer was positive in 4.8%. The most frequent presenting symptoms included pain (63.8%), weight loss (63%) and jaundice (52.5%). The reported frequency of smoking and alcohol consumption was lower than expected (28.5% and 27.4%, respectively). The majority of patients (75.6%) were diagnosed with advanced disease. Most patients (83.6%) had a primary tumor located in the pancreatic head. The histological diagnosis was ductal adenocarcinoma in 90.7% of the cases, while neuroendocrine tumor was present in 5.3%. Biliary stent implantation was performed in 166 patients, 59.2% of them received metal stents. Primary tumor resection was performed in 60 (16.9%) patients. Enteral or biliary bypass was done in 35 and 49 patients, respectively. In a multivariate Cox-regression model, smoking status and presence of gemcitabine-based chemotherapy were identified as independent predictors for overall survival.
Conclusion: We report the first data from a large cohort of Hungarian pancreatic cancer patients. We identified smoking status and chemotherapy as independent predictors in this cohort.
Abbreviations: EBM: evidence-based medicine; EPI: exocrine pancreatic insufficiency; FNAB: fine needle aspiration biopsy; HPSG: Hungarian Pancreatic Study Group; MDCT: multi-detector computed tomography; OS: overall survival; PC: pancreatic cancer; RPP: Registry for Pancreatic Patients